Gauging the Antiobesity Potential of Oral Semaglutide in Type 2 Diabetes in the Indian Context. IJCP. 2023;33(11):8-12. Accessed April 3, 2025. https://ojs.ijcp.in/index.php/IJCP/article/view/147